A 2021 study reported that Ozempic use increased the risk of deep vein thrombosis (DVT), a condition caused by blood clotting deep in the body
Zydus has explicitly framed its offering as an Indiafirst style adjustable, reusable singlepen approach intended to reduce the need for multiple pens and lower overall therapy costs
By using liposomal delivery technology, glutathione is encapsulated in lipid-based carriers to help protect it during digestion and improve stability compared with standard oral formats
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Some programs look affordable upfront, but the cost can change once provider visits, dose changes, supplies, or follow-ups are added
Organ preservation: from the past to the future